After a 28-day period of exposure to monotherapy, PTX-PPI, or CD44 siRNA-PPI, tumours derived from cells isolated from the malignant ascites of patients with advanced ovarian carcinoma continued to grow. The gene discussed is CD44; the disease is neoplasm.